Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with advanced chronic kidney disease and coronavirus disease 2019

GCK Chan, GCY Lui, CNS Wong… - Clinical Infectious …, 2023 - academic.oup.com
Background Nirmatrelvir-ritonavir is currently not recommended in patients with an
estimated glomerular filtration rate (eGFR)< 30 mL/minute/1.73 m2. Methods To determine …
被引用次数：7 相关文章

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease …

GCK Chan, GCY Lui, CNS Wong, SST Yip… - … Diseases: an Official …, 2023 - europepmc.org
Background Nirmatrelvir-ritonavir is currently not recommended in patients with an
estimated glomerular filtration rate (eGFR)< 30 mL/minute/1.73 m2. Methods To determine …

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease …

GCK Chan, GCY Lui, CNS Wong… - Clinical Infectious …, 2023 - academic.oup.com
Background Nirmatrelvir-ritonavir is currently not recommended in patients with an
estimated glomerular filtration rate (eGFR)< 30 mL/minute/1.73 m2. Methods To determine …

Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease …

GCK Chan, GCY Lui, CNS Wong… - … publication of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Nirmatrelvir-ritonavir is currently not recommended in patients with an
estimated glomerular filtration rate (eGFR)< 30 mL/minute/1.73 m2. Methods To determine …